Article citationsMore>>
C. Zhou, Y. L. Wu, G. Chen, et al., “Erlotinib versus Chemotherapy as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer (OPTIMAL, CTONG-0802): A Multicentre, Open-Label, Randomised, Phase 3 Study,” Lancet Oncology, Vol. 12, No. 8, 2011, pp. 735-742.
doi:10.1016/S1470-2045(11)70184-X
has been cited by the following article:
Related Articles:
-
Tetsuya Kubota, Yoshio Okano, Mizu Sakai, Takashi Yamane, Naoki Shiota, Hiroshi Ohnishi, Hisanori Machida, Nobuo Hatakeyama, Eiji Takeuchi, Tomoyuki Urata, Fumitaka Ogushi, Akihito Yokoyama
-
Saki Manabe, Fumihiro Oshita, Shuji Murakami, Tetsuro Kondo, Haruhiro Saito, Takeshi Kaneko, Kouzo Yamada
-
Amen Hamdy Zaky, Ahmed Refaat Abd Elzaher, Ola Nabih
-
Xianshan Chen, Juncheng Guo, Min Guo
-
Milan Rancic, Lidija Ristic, Marina Cekic, Tatjana Pejcic